Medochemie history
scrollup scrolldown
1976 Dr. Andreas Pittas founded Medochemie Ltd as a manufacturer of generic pharmaceuticals.
1983 First Cyprus Export Award for Industry.
1985 Cyprus Export Award for Industry.
1987 Cyprus Export Award for Industry.
1990 Cyprus Export Award for Industry.
1991 European Union Award for Outstanding Business Performance;Opening of Singapore Office.
1992 Opening of office in Russia.
1993 Opening of offices in Bulgaria and the Czech Republic.
1994 Medochemie Research Institute founded.Opening of offices in Romania and Slovakia.
1995 European Union Award for Outstanding Business Performance. Cyprus Export Award for Industry.
1996 Chemical Industry Safety Award.
1997 Opening of Representative office in Yugoslavia.
1998 Chemical Industry Safety Award.Opening of offices in Vietnam and Ukraine.Opening of GDP (Good Distribution Practice) warehouse facilities in Russia. Opening of Medochemie marketing company, with additional development laboratory facilities, in Greece.
1999 European Union Award for Outstanding Business Performance.
2000 Commissioning and validation of additional manufacturing facilities at third manufacturing site.
2001 Commencement of production in the new manufacturing site in Limassol. Acquisition of the Dutch pharmaceutical manufacturing group FAL. Opening of offices in Holland, Thailand, Lithuania and Kazakhstan. Design and construction of new inhalation therapy manufacturing unit in Cyprus commences. Special architectural award presented by H.E the President of Cyprus Glafkos Clerides for the design of the new manufacturing site. The Cyprus Special Export Award.
2002 Following GMP inspection by an E.U competent authority, the GMP status of our facilities was confirmed. The Cyprus Export Award for Industrial Products.
2003 Dry powder inhaler facility was completed, fully validated, GMP inspected and started activity. The Cyprus Special Export Award for Andi – Ventis Opening of office in Belarus. Chemical Industry Safety Award.
2004 Refurbishment at our creams, ointment and suppositories facilities was completed, GMP inspected, and started operations. Chemical Industry Safety Award. Special Recognition from MSF (Medicins Sans Frontieres) – Cyprus. Opening of offices in Algeria, Moldova and Latvia.
2005 Following GMP inspection by PICS Member Authorities, the GMP status of our facilities was confirmed. New ampoules facility was completed, and started operations. New packaging facility was completed and started operations. Cyprus Export Award for Industry.
2007 Cyprus Export Award for Industry.
2008 In Business Award 2008.